Graham Capital Management, L.P.
Position in BDTX — Black Diamond Therapeutics, Inc.
CIK 1315421
ROWAYTON, CT
Position in BDTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$364,014
+$153,683 QoQ
Shares Held
170,899
+97.4% QoQ
Ownership
0.298%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BDTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Graham Capital Management, L.P. holds $14,536,772 across 66 Biotechnology names. BDTX ranks #13 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
4,606 | $870,764 | |
| 2 | TECH |
BIO-TECHNE Corp
|
9,949 | $519,934 | |
| 3 | SRPT |
Sarepta Therapeutics, Inc.
|
22,442 | $488,337 | |
| 4 | BHVN |
Biohaven Ltd.
|
55,399 | $468,675 | |
| 5 | NUVL |
Nuvalent, Inc.
|
4,112 | $421,274 | |
| 6 | ADMA |
Adma Biologics, Inc.
|
45,222 | $407,450 | |
| 7 | MNKD |
Mannkind Corp
|
161,189 | $394,913 | |
| 8 | ABCL |
AbCellera Biologics Inc.
|
112,831 | $393,780 |
All Filings in BDTX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $364,014 | 170,899 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $210,331 | 86,556 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $138,414 | 36,521 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $178,609 | 72,020 | Shares | Sole | 2025-08-14 | |
| 2023-12-31 | $241,148 | 85,818 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||